Context Therapeutics
Post in 2024
Context Therapeutics LLC is a clinical-stage biopharmaceutical company based in Philadelphia, Pennsylvania, focused on developing innovative therapies for hormone-responsive cancers. Founded in 2015, the company’s primary aim is to address female hormone-dependent cancers, including breast, ovarian, and endometrial cancer. Context's lead program is Apristor (Onapristone XR), an investigational drug currently in Phase 2 trials for treating progesterone receptor positive metastatic breast and ovarian cancers. The company is also advancing CTX-030916, a potential oral antiprogestin designed for uterine fibroids and endometriosis. Additionally, Context is engaged in a discovery-stage program targeting Sigma1 and has developed CTIM-76, a bispecific antibody aimed at redirecting T-cell-mediated lysis towards malignant cells expressing CLDN6. Through its focused pipeline, Context Therapeutics is committed to creating effective treatments for patients with solid tumors.
AIR Communities
Acquisition in 2024
Apartment Income REIT Corp., also known as AIR Communities, owns and operates apartment communities throughout the United States. AIR Communities manages properties professionally in the majority of major markets, including Boston, Philadelphia, Los Angeles, and Miami.
Harmony Biosciences
Post in 2021
Harmony Biosciences, established in 2017 and based in Plymouth Meeting, Pennsylvania, is a biopharmaceutical company focused on developing and commercializing therapies for patients with rare neurological disorders. Its primary product, WAKIX (pitolisant), is a first-in-class medication designed to increase histamine signaling in the brain, approved for treating cataplexy in adult narcolepsy patients. Harmony Biosciences operates as a subsidiary of Harmony Biosciences Holdings, Inc., which is dedicated to addressing unmet medical needs in this therapeutic area.
Harvest Fund Advisors
Acquisition in 2017
Harvest Fund Advisors, founded in 2005 and based in the suburbs of Philadelphia, specializes in actively managed investment solutions focused on public market energy infrastructure and master limited partnerships (MLPs). The firm primarily serves institutional investors, including real estate investment trusts and business development companies, and manages over $10 billion in assets. Harvest aims to generate strong risk-adjusted returns for its clients by raising capital through separately managed accounts and pooled vehicles that invest in U.S. midstream energy assets, such as pipelines. The company is dedicated to addressing the unique needs of its investors consistently.
Philadelphia Financial Group
Acquisition in 2014
Philadelphia Financial Group is a global specialty insurer and administration company that offers innovative solutions combining insurance and investment management. The firm aims to provide clients worldwide with opportunities to grow their wealth more effectively. It delivers a range of services, including private placement, insurance administration, and investment advisory services, catering to insurance brokers, financial advisors, private banks, law firms, and accounting firms. As an indirect subsidiary of Tiptree Financial, Philadelphia Financial plays a vital role in the broader financial services sector, which encompasses insurance services, specialty finance, asset management, and real estate.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.